Skip to main content
HR 9616 118th Congress House Health Drug safety, medical device, and laboratory regulation Marketing and advertising

Prompt Approval of Safe Generic Drugs Act

Introduced: September 17, 2024 Introduced by: Barragán, Nanette Diaz Democratic · California See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 17, 2024
Referred to the House Committee on Energy and Commerce.
Sep 17, 2024
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now September 17, 2024

Referred to the House Committee on Energy and Commerce.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 9616: Prompt Approval of Safe Generic Drugs Act. 118th Congress. Open America. https://openamerica.io/bill/118-HR-9616/
MLA
"H.R. 9616: Prompt Approval of Safe Generic Drugs Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-9616/.
Bluebook (legal)
H.R. 9616, 118th Cong. (2026), https://openamerica.io/bill/118-HR-9616/.
Markdown link
[H.R. 9616: Prompt Approval of Safe Generic Drugs Act](https://openamerica.io/bill/118-HR-9616/)
Report a problem